Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
Public ClinicalTrials.gov record NCT01110720. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2/3, Randomized, Double-Blind, Placebo-Controlled, Study to Evaluate the Safety and Efficacy of Davunetide for the Treatment of Progressive Supranuclear Palsy
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of the study is to evaluate the safety and efficacy of davunetide for the treatment of Progressive Supranuclear Palsy.
Study identification
- NCT ID
- NCT01110720
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2, Phase 3
- Enrollment
- 313 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 41 Years to 85 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 2010 (Type not available)
- Primary completion
- Nov 2012 (Actual)
- Completion
- Dec 2012 (Actual)
- Last update posted
- Jan 17, 2013
2010 – 2012
United States locations
- U.S. sites
- 28
- U.S. states
- 19
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama - Birmingham | Birmingham | Alabama | 35294 | — |
| Muhammed Ali Parkinson Center and Movement Disorders Clinic | Phoenix | Arizona | 85013 | — |
| Mayo Clinic, AZ | Scottsdale | Arizona | 85259 | — |
| USC Keck School of Medicine | Los Angeles | California | 90033 | — |
| David Geffen School of Medicine - UCLA | Los Angeles | California | 90095 | — |
| UCSD/VA Neurology Service | San Diego | California | 92161 | — |
| UCSF Memory and Aging Center | San Francisco | California | 94143 | — |
| Colorado Neurological Institute - Rocky Mountain Movement Disorders Ctr, PC | Englewood | Colorado | 80113 | — |
| Parkinson's Disease and Movement Disorders Center of Boca Raton | Boca Raton | Florida | 33486 | — |
| Mayo Clinic, Florida | Jacksonville | Florida | 32224 | — |
| The Frances J. Zesiewicz Foundation for Parkinson's Disease at USF | Tampa | Florida | 33612 | — |
| University of Chicago Medical Center | Chicago | Illinois | 60637 | — |
| University of Kansas Medical Center Parkinson Disease & Movement Disorders Center | Kansas City | Kansas | 66160 | — |
| University of Louisville Division of Movement Disorders | Louisville | Kentucky | 40202 | — |
| John Hopkins Hospital | Baltimore | Maryland | 21287 | — |
| Massachusetts General Hospital | Boston | Massachusetts | 02115 | — |
| Lahey Clinic | Burlington | Massachusetts | 01805 | — |
| University of Michigan Medical Center | Ann Arbor | Michigan | 48109 | — |
| University of Minnesota Department of Neuology | Minneapolis | Minnesota | 55455 | — |
| Mayo Clinic, Rochester, MN | Rochester | Minnesota | 55905 | — |
| UMDNJ - Robert Wood Johnson Medical Center | New Brunswick | New Jersey | 08901 | — |
| Columbia University | New York | New York | 10032 | — |
| Univeristy of North Carolina Department of Neurology | Chapel Hill | North Carolina | 27599 | — |
| University Hospitals Case Medical CenterNI Movement Disorders Center | South Euclid | Ohio | 44121 | — |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | — |
| University of Texas Southwestern Medical Center | Dallas | Texas | 75390 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| University of Utah Center for Alzheimer's Care, Imaging &Research | Salt Lake City | Utah | 84108 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01110720, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jan 17, 2013 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01110720 live on ClinicalTrials.gov.